• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Lower-dose levonorgestrel IUD effective, well-tolerated

bys25qthea
November 17, 2013
in Chronic Disease, Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Lower-dose 13.5 mg and 19.5 mg levonorgestrel intrauterine contraceptive systems (IUDs) were found to be highly effective for up to 3 years. 

2.  Both devices were easy to insert and well tolerated by paras and nulliparas.

Evidence Rating Level: 1 (Excellent)       

Study Rundown: This phase III clinical trial found that the newly developed, lower-hormone levonorgestrel IUDs were highly effective, relatively easy to insert, and well-tolerated for up to 3 years. These lower-dose IUDs have smaller frames and findings from Phase II trials suggest they are easier to insert than traditional IUDs.

Strengths of this study include large sample size and multi-site, multi-national cohort. limited in that it only included women with regular menstrual cycles, and thus could not evaluate efficacy with regards to abnormal uterine bleeding, a common indication for IUDs. Future studies might randomize women to the smaller, lower-dose versus Mirena IUD to assess contraceptive efficacy as well as treatment of abnormal uterine bleeding.

RELATED REPORTS

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

Postpartum patients may be at an increased risk of intrauterine device-related perforation

Click to read the study in Obstetrics & Gynecology

Click to read the study overview on clinicaltrials.gov

Relevant Reading: Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system

In-Depth [randomized controlled trial]: In this Phase III single-blinded trial, researchers from 138 centers around the globe randomized 2,885 women to either a 13.5 mg (n=1,426) or 19.5 mg (n=1,445) levonorgestrel intrauterine contraceptive device (IUD) for three years. The primary outcome was pregnancy rate (number of pregnancies/100 women-years). Secondary outcomes included bleeding patterns, ease of placement, safety, continuation and user satisfaction.

Over a 3-year study period, women with the IUD were less likely to become pregnant: 0.33 (95% CI=0.16-0.60) for the 13.5mg IUD and 0.31 (CI=0.15-0.57) for the 19.5 mg IUD. Cumulative failure rates were 0.9% for the 13.5 mg and 1.0% for the 19.5 mg system. Overall, placement was successful in over 99.5%, placement was rated as easy by physicians in 90% of patients and only 8% of women rated severe pain associated with placement. Discontinuation rates were 21.9% and 19.1% in the 13.5 mg and 19.5 mg groups, respectively.

By Maren Shapiro and Leah Hawkins, MD, MPH

More from this author: IUD contraception equally safe in teenagers as in older women, Black men less likely to receive follow-up for elevated prostate cancer marker, PSA, USPSTF recommends chemoprevention for women at high risk for breast cancer,

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: contraceptionIUDLevonorgestrel
Previous Post

Multiple births associated with increased healthcare costs

Next Post

Early retroviral therapy reduces HIV-1 transmission [Classics Series]

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

April 16, 2024
1 in 5 US women report delayed contraceptive initiation after sexual debut
Emergency

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

September 27, 2023
AAP policy update recommends first-line contraceptives, addresses special populations
Emergency

Postpartum patients may be at an increased risk of intrauterine device-related perforation

June 15, 2022
Family planning providers use long acting contraception more than general population
Obstetrics

Immediate postpartum intrauterine device insertion associated with increased risk of device expulsion: the APEX-IUD study

February 28, 2022
Next Post

Early retroviral therapy reduces HIV-1 transmission [Classics Series]

Childhood migraine associated with infantile colic

Novel prion disease associated with diarrhea and autonomic neuropathy

Successful regional implementation of pediatric chest pain algorithm

EHR useful for pediatric health insurance surveillance

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
  • Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.